Cardiac Rhythm Management

Latest News for 2018

shadow-div-content

The Heart Rhythm Society Releases Communication Strategies for Cybersecurity Threats to Cardiovascular Implantable Electronic Devices

Read more...

Affera's Novel Technology for Cardiac Arrhythmia Treatment to be Featured in Eight Scientific Sessions at the 2018 Heart Rhythm Society Meeting

Read more...

Bardy Diagnostics™ Announces Validation of AI-enabled Automatic Screening Technology for Atrial Fibrillation

Read more...

Biosense Webster, Inc. Launches Sheath Designed to Reduce Radiation Exposure and Improve Ablation Procedure Efficiency

Read more...

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter

Read more...

Bardy Diagnostics™ Announces Results of Head-to-Head Comparison of Patch-Based Arrhythmia Monitors

Read more...

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

Read more...

Biosense Webster, Inc. Launches Study To Evaluate Novel High Power, Short Duration Modality For Treatment Of Atrial Fibrillation

Read more...

More Articles...

Advertisement